Melanoma March is just around the corner!
1 November 2017
Melanoma March is just around the corner and we’re excited to announced that this year will be bigger than ever, and a little bit different. In addition to 20 much-loved Melanoma March events across the country, we are introducing a run component to our Melbourne March. For Sydney Marchers, we are returning to Manly and adding a stand-up paddle option as well. There’s something for everyone!
We are also delighted to announce that fitness guru and melanoma survivor Shannan Ponton is once again joining us as our official 2018 Melanoma March Ambassador. Shannan is proof that melanoma can strike anyone. He says he’s one of the lucky ones, as despite undergoing two rounds of surgery and now sporting a 20cm scar, his melanoma hadn’t spread. “Melanoma doesn’t discriminate and it is vital that everyone protects themselves and their families from the sun,” Shannan said. “Melanoma March is a fun family event that not only serves as a timely reminder about the importance of sun-safety, but it also supports life-saving research. Living a sun-smart lifestyle, early detection and investing in research are crucial if Australia is to win the melanoma battle,” he said.
Shannan is urging all Australians to sign up for a Melanoma March event near them, and then spread the word with their family and friends.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.